231 related articles for article (PubMed ID: 26644349)
1. Cytosolic phospholipase A2α regulates G1 progression through modulating FOXO1 activity.
Naini SM; Choukroun GJ; Ryan JR; Hentschel DM; Shah JV; Bonventre JV
FASEB J; 2016 Mar; 30(3):1155-70. PubMed ID: 26644349
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic phospholipase A2α sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells.
Hua S; Yao M; Vignarajan S; Witting P; Hejazi L; Gong Z; Teng Y; Niknami M; Assinder S; Richardson D; Dong Q
Biochim Biophys Acta; 2013 Jun; 1831(6):1146-57. PubMed ID: 23500889
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
4. cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells.
Fu H; He Y; Qi L; Chen L; Luo Y; Chen L; Li Y; Zhang N; Guo H
Cancer Lett; 2017 Sep; 403():260-270. PubMed ID: 28649002
[TBL] [Abstract][Full Text] [Related]
5. Cytosolic phospholipase A
Montford JR; Lehman AM; Scobey MS; Weiser-Evans MC; Nemenoff RA; Furgeson SB
Prostaglandins Other Lipid Mediat; 2016 Nov; 126():1-8. PubMed ID: 27554058
[TBL] [Abstract][Full Text] [Related]
6. Targeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells.
Yao M; Xie C; Kiang MY; Teng Y; Harman D; Tiffen J; Wang Q; Sved P; Bao S; Witting P; Holst J; Dong Q
Oncotarget; 2015 Oct; 6(33):34458-74. PubMed ID: 26416244
[TBL] [Abstract][Full Text] [Related]
7. AKT and cytosolic phospholipase A2α form a positive loop in prostate cancer cells.
Hua S; Vignarajan S; Yao M; Xie C; Sved P; Dong Q
Curr Cancer Drug Targets; 2015; 15(9):781-91. PubMed ID: 26143945
[TBL] [Abstract][Full Text] [Related]
8. Activation of cytosolic phospholipase A2alpha in resident peritoneal macrophages by Listeria monocytogenes involves listeriolysin O and TLR2.
Noor S; Goldfine H; Tucker DE; Suram S; Lenz LL; Akira S; Uematsu S; Girotti M; Bonventre JV; Breuel K; Williams DL; Leslie CC
J Biol Chem; 2008 Feb; 283(8):4744-55. PubMed ID: 18083708
[TBL] [Abstract][Full Text] [Related]
9. Cytosolic phospholipase A2α enhances mouse mortality induced by Pseudomonas aeruginosa pulmonary infection via interleukin 6.
Guillemot L; Medina M; Pernet E; Leduc D; Chignard M; Touqui L; Wu Y
Biochimie; 2014 Dec; 107 Pt A():95-104. PubMed ID: 25201511
[TBL] [Abstract][Full Text] [Related]
10. Cytosolic phospholipase A2 modulates TLR2 signaling in synoviocytes.
Sommerfelt RM; Feuerherm AJ; Skuland T; Johansen B
PLoS One; 2015; 10(4):e0119088. PubMed ID: 25893499
[TBL] [Abstract][Full Text] [Related]
11. Targeting cPLA2α inhibits gastric cancer and augments chemotherapy efficacy via suppressing Ras/MEK/ERK and Akt/β-catenin pathways.
Liao Y; Chen W; Shi W; Zha H
Cancer Chemother Pharmacol; 2021 Oct; 88(4):689-697. PubMed ID: 34255137
[TBL] [Abstract][Full Text] [Related]
12. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
[TBL] [Abstract][Full Text] [Related]
13. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
14. Cellular Assays for Evaluating Calcium-Dependent Translocation of cPLA
Yun B; Leslie CC
Methods Enzymol; 2017; 583():71-99. PubMed ID: 28063500
[TBL] [Abstract][Full Text] [Related]
15. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
Zhao Z; Li C; Xi H; Gao Y; Xu D
Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
[TBL] [Abstract][Full Text] [Related]
16. cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.
Chen L; Fu H; Luo Y; Chen L; Cheng R; Zhang N; Guo H
Cell Death Dis; 2017 Apr; 8(4):e2728. PubMed ID: 28383549
[TBL] [Abstract][Full Text] [Related]
17. Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression.
Charvet C; Canonigo AJ; Bécart S; Maurer U; Miletic AV; Swat W; Deckert M; Altman A
J Immunol; 2006 Oct; 177(8):5024-31. PubMed ID: 17015685
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cytosolic phospholipase A2 (cPLA2alpha) and its association with cell proliferation in human lens epithelial cells.
Wang Y; Xing KY; Lou MF
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8231-40. PubMed ID: 21896865
[TBL] [Abstract][Full Text] [Related]
19. Cytokine-induced phosphoinositide 3-kinase activity promotes Cdk2 activation in factor-dependent hematopoietic cells.
Henry MK; Nimbalkar D; Hohl RJ; Quelle FW
Exp Cell Res; 2004 Sep; 299(1):257-66. PubMed ID: 15302592
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cytosolic phospholipase A2 alpha increases chemosensitivity in cervical carcinoma through suppressing β-catenin signaling.
Xu H; Sun Y; Zeng L; Li Y; Hu S; He S; Chen H; Zou Q; Luo B
Cancer Biol Ther; 2019; 20(6):912-921. PubMed ID: 30829552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
